AYTU BIOPHARMA, INC Depreciation
AYTU BIOPHARMA, INC (AYTU) reported Depreciation of $100.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-09-22
- AYTU BIOPHARMA, INC depreciation for the quarter ending 2026-06-30 was $0.00.
- AYTU BIOPHARMA, INC depreciation for the quarter ending 2026-03-31 was $100.00K, a 0.00% change year-over-year.
- AYTU BIOPHARMA, INC depreciation for the quarter ending 2025-12-31 was $100.00K, a 0.00% change year-over-year.
- AYTU BIOPHARMA, INC depreciation for the quarter ending 2025-09-30 was $100.00K, a 0.00% change year-over-year.
- AYTU BIOPHARMA, INC depreciation for fiscal 2026 was $100.00K, a 50.00% decline from fiscal 2025.
- AYTU BIOPHARMA, INC depreciation for fiscal 2025 was $200.00K, a 77.78% decline from fiscal 2024.
- AYTU BIOPHARMA, INC depreciation for fiscal 2024 was $900.00K, a 30.77% decline from fiscal 2023.
- AYTU BIOPHARMA, INC depreciation for fiscal 2023 was $1.30M, a 18.75% decline from fiscal 2022.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 81 month | Depreciation 84 month | Depreciation 87 month | Depreciation 90 month | Depreciation 93 month | Depreciation 96 month | Depreciation 99 month | Depreciation 102 month | Depreciation 105 month | Depreciation 108 month | Depreciation 111 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $100.00K derived: sum of 2 quarters · filed 2026-09-22 | $200.00K derived: sum of 3 quarters · filed 2026-09-22 | $100.00K 10-K · filed 2026-09-22 | |||||||||||
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-13 | $200.00K derived: sum of 2 quarters · filed 2026-05-13 | $100.00K 10-Q · filed 2026-05-13 | $300.00K derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||
| 2025-12-31 | $100.00K 10-Q · filed 2026-02-03 | $100.00K 10-Q · filed 2026-02-03 | $200.00K derived: sum of 3 quarters · filed 2026-09-22 | $300.00K derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||
| 2025-09-30 | $100.00K 10-Q · filed 2025-11-13 | $100.00K derived: sum of 2 quarters · filed 2026-09-22 | $200.00K derived: sum of 3 quarters · filed 2026-09-22 | $300.00K derived: sum of 4 quarters · filed 2026-09-22 | |||||||||||
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-22 | $100.00K derived: sum of 2 quarters · filed 2026-09-22 | $200.00K derived: sum of 3 quarters · filed 2026-09-22 | $200.00K 10-K · filed 2026-09-22 | |||||||||||
| 2025-03-31 | $100.00K 10-Q · filed 2026-05-13 | $200.00K derived: sum of 2 quarters · filed 2026-05-13 | $200.00K 10-Q · filed 2026-05-13 | $400.00K derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||
| 2024-12-31 | $100.00K 10-Q · filed 2026-02-03 | $100.00K 10-Q · filed 2026-02-03 | $300.00K derived: sum of 3 quarters · filed 2026-02-03 | $500.00K derived: sum of 4 quarters · filed 2026-02-03 | |||||||||||
| 2024-09-30 | $100.00K 10-Q · filed 2025-11-13 | $200.00K derived: sum of 2 quarters · filed 2025-11-13 | $400.00K derived: sum of 3 quarters · filed 2025-11-13 | $700.00K derived: sum of 4 quarters · filed 2025-11-13 | |||||||||||
| 2024-06-30 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $300.00K derived: sum of 2 quarters · filed 2025-09-23 | $600.00K derived: sum of 3 quarters · filed 2025-09-23 | $900.00K 10-K · filed 2025-09-23 | |||||||||||
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-14 | $500.00K derived: sum of 2 quarters · filed 2025-05-14 | $800.00K 10-Q · filed 2025-05-14 | $1.10M derived: sum of 4 quarters · filed 2025-05-14 | |||||||||||
| 2023-12-31 | $300.00K 10-Q · filed 2025-02-12 | $600.00K 10-Q · filed 2025-02-12 | $900.00K derived: sum of 3 quarters · filed 2025-02-12 | $1.20M derived: sum of 4 quarters · filed 2025-02-12 | |||||||||||
| 2023-09-30 | $300.00K 10-Q · filed 2023-11-14 | $600.00K derived: sum of 2 quarters · filed 2024-09-26 | $900.00K derived: sum of 3 quarters · filed 2024-09-26 | $1.30M derived: sum of 4 quarters · filed 2024-09-26 | |||||||||||
| 2023-06-30 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-26 | $600.00K derived: sum of 2 quarters · filed 2024-09-26 | $1.00M derived: sum of 3 quarters · filed 2024-09-26 | $1.30M 10-K · filed 2024-09-26 | |||||||||||
| 2023-03-31 | $300.00K 10-Q · filed 2024-05-15 | $700.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.00M 10-Q · filed 2024-05-15 | $1.30M derived: sum of 4 quarters · filed 2024-05-15 | |||||||||||
| 2022-12-31 | $400.00K 10-Q · filed 2024-02-14 | $700.00K 10-Q · filed 2024-02-14 | $1.00M derived: sum of 3 quarters · filed 2024-02-14 | $1.50M derived: sum of 4 quarters · filed 2024-02-14 | |||||||||||
| 2022-09-30 | $300.00K 10-Q · filed 2023-11-14 | $600.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.10M derived: sum of 3 quarters · filed 2023-11-14 | $1.50M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||
| 2022-06-30 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-12 | $800.00K derived: sum of 2 quarters · filed 2023-10-12 | $1.20M derived: sum of 3 quarters · filed 2023-10-12 | $1.60M 10-K · filed 2023-10-12 | |||||||||||
| 2022-03-31 | $500.00K 10-Q · filed 2023-05-11 | $900.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.30M 10-Q · filed 2023-05-11 | $1.80M derived: sum of 4 quarters · filed 2023-05-11 | |||||||||||
| 2021-12-31 | $400.00K 10-Q · filed 2023-02-21 | $800.00K 10-Q · filed 2023-02-21 | $1.30M derived: sum of 3 quarters · filed 2023-02-21 | $1.40M derived: sum of 4 quarters · filed 2023-02-21 | |||||||||||
| 2021-09-30 | $400.00K 10-Q/A · filed 2023-02-21 | $900.00K derived: sum of 2 quarters · filed 2023-02-21 | $1.00M derived: sum of 3 quarters · filed 2023-02-21 | $1.02M derived: sum of 4 quarters · filed 2023-02-21 | |||||||||||
| 2021-06-30 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $600.00K derived: sum of 2 quarters · filed 2022-09-27 | $618.00K derived: sum of 3 quarters · filed 2022-09-27 | $600.00K 10-K · filed 2022-09-27 | |||||||||||
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-16 | $118.00K derived: sum of 2 quarters · filed 2022-05-16 | $100.00K 10-Q · filed 2022-05-16 | ||||||||||||
| 2020-12-31 | $18.00K 10-Q · filed 2022-02-14 | $100.00K 10-Q · filed 2022-02-14 | |||||||||||||
| 2020-09-30 | $33.00K 10-Q · filed 2021-11-15 | ||||||||||||||
| 2020-06-30 | $100.00K 10-K · filed 2021-09-28 | ||||||||||||||
| 2017-09-30 | $80.00K 10-Q · filed 2017-11-09 | $142.00K derived: sum of 2 quarters · filed 2017-11-09 | $169.00K derived: sum of 3 quarters · filed 2017-11-09 | $195.00K derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||
| 2017-06-30 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $89.00K derived: sum of 2 quarters · filed 2017-08-31 | $115.00K derived: sum of 3 quarters · filed 2017-08-31 | $134.00K 10-K · filed 2017-08-31 | |||||||||||
| 2017-03-31 | $27.00K 10-Q · filed 2017-05-11 | $53.00K derived: sum of 2 quarters · filed 2017-05-11 | $72.00K 10-Q · filed 2017-05-11 | $86.00K derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||
| 2016-12-31 | $26.00K 10-Q · filed 2017-02-09 | $45.00K 10-Q · filed 2017-02-09 | $59.00K derived: sum of 3 quarters · filed 2017-11-09 | $77.00K derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||
| 2016-09-30 | $19.00K 10-Q · filed 2017-11-09 | $33.00K derived: sum of 2 quarters · filed 2017-11-09 | $51.00K derived: sum of 3 quarters · filed 2017-11-09 | $63.00K derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||
| 2016-06-30 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-31 | $32.00K derived: sum of 2 quarters · filed 2017-08-31 | $44.00K derived: sum of 3 quarters · filed 2017-08-31 | $51.00K 10-K · filed 2017-08-31 | |||||||||||
| 2016-03-31 | $18.00K 10-Q · filed 2017-05-11 | $30.00K derived: sum of 2 quarters · filed 2017-05-11 | $37.00K 10-Q · filed 2017-05-11 | ||||||||||||
| 2015-12-31 | $12.00K 10-Q · filed 2017-02-09 | $19.00K 10-Q · filed 2017-02-09 | |||||||||||||
| 2015-09-30 | $7.00K 10-Q · filed 2016-11-07 | ||||||||||||||
| 2015-06-30 | $27.00K 10-K · filed 2016-09-01 | ||||||||||||||
| 2015-02-28 | $1.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | $2.36K 10-Q · filed 2015-04-15 | |||||||||||||
| 2014-11-30 | $1.20K 10-Q · filed 2015-01-12 | ||||||||||||||
| 2014-06-30 | $27.00K 10-K · filed 2015-09-28 | ||||||||||||||
| 2014-05-31 | $1.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | $2.39K derived: sum of 2 quarters · filed 2015-04-15 | $3.59K 10-Q · filed 2014-07-10 | $4.78K derived: sum of 4 quarters · filed 2015-04-15 | $61.94K 10-Q · filed 2014-07-10 | ||||||||||
| 2014-02-28 | $1.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-04-15 | $2.39K 10-Q · filed 2015-04-15 | $3.58K derived: sum of 3 quarters · filed 2015-04-15 | $4.80K derived: sum of 4 quarters · filed 2015-04-15 | $60.74K 10-Q · filed 2014-04-11 | ||||||||||
| 2013-11-30 | $1.20K 10-Q · filed 2015-01-12 | $2.39K derived: sum of 2 quarters · filed 2015-01-12 | $3.60K derived: sum of 3 quarters · filed 2015-01-12 | $4.85K derived: sum of 4 quarters · filed 2015-01-12 | $59.55K 10-Q · filed 2014-01-10 | ||||||||||
| 2013-08-31 | $1.19K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $2.41K derived: sum of 2 quarters · filed 2014-11-26 | $3.66K derived: sum of 3 quarters · filed 2014-11-26 | $4.94K 10-K · filed 2014-11-26 | $58.35K 10-K · filed 2014-11-26 | ||||||||||
| 2013-05-31 | $1.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-07-10 | $2.46K derived: sum of 2 quarters · filed 2014-07-10 | $3.75K 10-Q · filed 2014-07-10 | $5.11K derived: sum of 4 quarters · filed 2014-11-26 | $57.16K 10-Q · filed 2013-06-28 | ||||||||||
| 2013-02-28 | $1.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-04-11 | $2.53K 10-Q · filed 2014-04-11 | $3.90K derived: sum of 3 quarters · filed 2014-11-26 | $5.36K derived: sum of 4 quarters · filed 2014-11-26 | $55.94K 10-Q · filed 2013-04-15 | ||||||||||
| 2012-11-30 | $1.29K 10-Q · filed 2014-01-10 | $2.65K derived: sum of 2 quarters · filed 2014-11-26 | $4.11K derived: sum of 3 quarters · filed 2014-11-26 | $5.77K derived: sum of 4 quarters · filed 2014-11-26 | $54.70K 10-Q · filed 2013-01-14 | ||||||||||
| 2012-08-31 | $1.36K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-26 | $2.83K derived: sum of 2 quarters · filed 2014-11-26 | $4.49K derived: sum of 3 quarters · filed 2014-11-26 | $6.15K 10-K · filed 2014-11-26 | $53.41K 10-K · filed 2012-11-29 | ||||||||||
| 2012-05-31 | $1.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-06-28 | $3.13K derived: sum of 2 quarters · filed 2013-06-28 | $4.79K 10-Q · filed 2013-06-28 | $6.45K derived: sum of 4 quarters · filed 2013-06-28 | $52.05K 10-Q · filed 2012-06-26 | ||||||||||
| 2012-02-29 | $1.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-15 | $3.32K 10-Q · filed 2013-04-15 | $4.99K derived: sum of 3 quarters · filed 2013-04-15 | $6.73K derived: sum of 4 quarters · filed 2013-04-15 | $50.58K 10-Q · filed 2012-04-12 | ||||||||||
| 2011-11-30 | $1.66K 10-Q · filed 2013-01-14 | $3.33K derived: sum of 2 quarters · filed 2013-01-14 | $5.06K derived: sum of 3 quarters · filed 2013-01-14 | $6.96K derived: sum of 4 quarters · filed 2013-01-14 | $48.92K 10-Q · filed 2011-12-23 | ||||||||||
| 2011-08-31 | $1.66K derived: 10-K 12 month − 10-Q 9 month · filed 2012-11-29 | $3.40K derived: sum of 2 quarters · filed 2012-11-29 | $5.29K derived: sum of 3 quarters · filed 2012-11-29 | $6.76K 10-K · filed 2012-11-29 | |||||||||||
| 2011-05-31 | $1.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-06-26 | $3.63K derived: sum of 2 quarters · filed 2012-06-26 | $5.10K 10-Q · filed 2012-06-26 | ||||||||||||
| 2011-02-28 | $1.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-04-12 | $3.36K 10-Q · filed 2012-04-12 | |||||||||||||
| 2010-11-30 | $1.47K 10-Q · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |